<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Dumusc SD</dc:creator>
  <dc:creator>Ontsouka EC</dc:creator>
  <dc:creator>Schnyder M</dc:creator>
  <dc:creator>Hartnack S</dc:creator>
  <dc:creator>Albrecht C</dc:creator>
  <dc:creator>Bruckmaier RM</dc:creator>
  <dc:creator>Burgener IA</dc:creator>
  <dc:date>2014</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND
Cyclooxygenase-2 (COX-2) is a key enzyme in the synthesis of pro-inflammatory prostaglandins and 5-lipoxygenase (5-LO) is the major source of leukotrienes. Their role in IBD has been demonstrated in humans and animal models, but not in dogs with chronic enteropathies (CCE).


HYPOTHESIS
COX-2 and 5-LO are upregulated in dogs with CCE.


ANIMALS
Fifteen healthy control dogs (HCD), 10 dogs with inflammatory bowel disease (IBD), and 15 dogs with food-responsive diarrhea (FRD).


METHODS
Prospective study. mRNA expression of COX-2, 5-LO, IL-1b, IL-4, IL-6, TNF, IL-10 and TFG-β was evaluated by quantitative real-time RT-PCR in duodenal and colonic biopsies before and after treatment.


RESULTS
COX-2 expression in the colon was significantly higher in IBD and FRD before and after treatment (all P &lt; .01). IL-1b was higher in FRD in the duodenum after treatment (P = .021). TGF-β expression was significantly higher in the duodenum of HCD compared to FRD/IBD before treatment (both P &lt; .001) and IBD after treatment (P = .012). There were no significant differences among groups and within groups before and after treatment for IL-4, IL-6, TNF, and IL-10. There was a significant correlation between COX-2 and IL-1b in duodenum and colon before treatment in FRD and IBD, whereas 5-LO correlated better with IL-6 and TNF. IL-10 and TGF-β usually were correlated.


CONCLUSIONS AND CLINICAL IMPORTANCE
COX-2 is upregulated in IBD and FRD, whereas IL-1b and TGF-β seem to be important pro- and anti-inflammatory cytokines, respectively. The use of dual COX/5-LO inhibitors could be an interesting alternative in the treatment of CCE.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/119444</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/jvim.12463</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/25269796</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Journal of veterinary internal medicine. - 2014</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Food-responsive diarrhea</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Inflammatory bowel disease</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Interleukin</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Leukotriene</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Arachidonate 5-Lipoxygenase</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Case-Control Studies</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Chronic Disease</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Colon</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Cyclooxygenase 2</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Diarrhea</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Dog Diseases</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Dogs</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Duodenum</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Inflammatory Bowel Diseases</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Interleukin-10</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Interleukin-1beta</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Interleukin-4</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Prospective Studies</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Real-Time Polymerase Chain Reaction</dc:subject>
  <dc:subject xmlns:ns23="xml" ns23:lang="en">Transforming Growth Factor beta</dc:subject>
  <dc:subject xmlns:ns24="xml" ns24:lang="en">Tumor Necrosis Factor-alpha</dc:subject>
  <dc:title xmlns:ns25="xml" ns25:lang="en">Cyclooxygenase-2 and 5-lipoxygenase in dogs with chronic enteropathies.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
